On November 12th, 2020, TRISOMY21- cluster held the first meeting. The focus of the meeting was to bring together the leadership of the TRISOMY21-cluster and a number of relevant stakeholders, from funding agencies to patient’s organisations and industry, to discuss priorities and opportunities for Down syndrome research and liaise with industry partners and patient representatives. During the meeting, consensus was built on research needs in the short and long term, and main objectives and priorities for action. Check out their consensus statement!
